START WITH THE BASICS
Three components.
A shared research question.
Can local radiotherapy and coordinated immune interventions work together against advanced cancer? PRaG is one research approach to that question.
PD-1 inhibition
Checkpoint inhibitors act on immune signaling that can restrain T-cell activity. Their effects depend on the tumor and treatment context.
Radiotherapy
Radiation treats selected tumor sites. Researchers also investigate its effects on tumor antigens and the surrounding immune environment.
GM-CSF
Granulocyte-macrophage colony-stimulating factor affects myeloid cells and antigen presentation. Its biology can be context dependent.
Where did the approach begin?
The Second Affiliated Hospital of Soochow University is central to the development of the PRaG program. Liyuan Zhang’s university profile describes this work beginning in 2019. A published phase II report in 2022 evaluated the original three-component regimen in 54 patients with previously treated metastatic solid tumors.
University profile ↗ · Read the phase II report →
How has the research evolved?
Later publications and trial registrations explore additional cytokines, antibody–drug conjugates, immune-modulating agents and different delivery strategies. These are distinct research questions. Our library separates the original PRaG regimen, PRaG-derived regimens and related research conducted under other study programs.
Read promise and uncertainty together.
Published responses provide reasons for further study. However, case reports and single-arm cohorts cannot by themselves establish superiority over standard treatment. Safety findings and less favorable observations are part of the evidence, too.
An early report including severe pneumonia → · Context-dependent immune biology →
Questions people ask
Is PRaG the same as proton therapy?
No. PRaG names a combination strategy involving checkpoint inhibition, radiotherapy and GM-CSF. The Chinese name “布拉格治疗” should not be read as a requirement to use proton beams.
Do higher version numbers mean better treatment?
No. The numbered regimens address different combinations or clinical questions. Only appropriate comparative evidence can establish whether one approach is better in a particular setting.
Does a complete response mean a cure?
A complete response describes the findings at a specified assessment under defined criteria. It does not by itself establish cure or eliminate the need for follow-up.
Can published results tell me whether this is right for me?
Research describes selected populations. Your diagnosis, previous treatments, overall health and clinical options need an individual assessment by your treating team.